WrittikaRoyMD

Clinical Trials

• A Study to Assess the Efficacy and Safety of REL-1017 as Monotherapy for Major Depressive Disorder (MDD) Start of enrollment: 2021 Jun 02

  Completed

  Phase 3

• A Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD) Start of enrollment: 2021 Mar 30

  Recruiting

  Phase 3

• Escitalopram in the Treatment of Adolescents With Major Depressive Disorder or Anxiety Disorders Start of enrollment: 2017 Apr 08

  Unknown status

  Phase 4

• Treatment of Impulsive Aggression (IA) in Adolescent With ADHD in Conjunction With Standard ADHD Treatment Start of enrollment: 2018 Jul 31

  Terminated

  Phase 3

• Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder Start of enrollment: 2021 Mar 30

  Enrolling by invitation

  Phase 3

• A Study of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant Depression Start of enrollment: 2020 Nov 04

  Completed

  Phase 4

• A Study to Investigate the Efficacy, Safety and Tolerability of Four Different Doses of BI 409306 Compared to Placebo Given for 12 Weeks in Patients With Schizophrenia on Stable Antipsychotic Treatment. Start of enrollment: 2014 Nov 10

  Completed

  Phase 2

• Join now to see all